Long-Term Results in Hairy Cell Leukemia Treated with 2-Chlorodeoxyadenosine
We treated 19 patients with hairy cell leukemia (HCL) with 2-chlorodeoxyadenosine. 15 patients followed up at least 6 months were evaluated. The follow up period varied between 6 months and 37 months (median, 19 months). 8 patients were previously treated. The overall response in 15 evaluable HCL pa...
Main Authors: | Ladislav Chrobák, Pavel Žák, Karel Podzimek, Lenka Plíšková, Jaroslava Foglová, Vladimír Maisnar, Petr Dulíček, Karel Dědič |
---|---|
Format: | Article |
Language: | English |
Published: |
Karolinum Press
1997-01-01
|
Series: | Acta Medica |
Subjects: | |
Online Access: | https://actamedica.lfhk.cuni.cz/40/2/0041/ |
Similar Items
-
2-chlorodeoxyadenosine treatment for cutaneous T-cell lymphoma
by: Malgorzata Sokolowska Wojdylo, et al.
Published: (2010-09-01) -
A Case of Xanthoma Disseminatum in a Progressive Form With Bladder Involvement Effectively Treated With 2-Chlorodeoxyadenosine
by: Elçin Akdaş, et al.
Published: (2023-04-01) -
A Case of Recurrent Rosai-Dorfman Disease Successfully Treated with 2-Chlorodeoxyadenosine (Cladribine)
by: Min Hyung Cho, et al.
Published: (2019-10-01) -
Experience of treatment of hairy cell leukemia with new drug Vero-cladribine
by: Yu. E. Ryabukhina, et al.
Published: (2022-11-01) -
Minimal Residual Disease, Its Detection and Significance in Hairy-Cell Leukemia
by: Pavel Žák, et al.
Published: (1999-01-01)